, Tracking Stock Market Picks
Enter Symbol:
Akebia Therapeutics Inc. (AKBA) [hlAlert]

down 45.90 %

Akebia Therapeutics Inc. (AKBA) rated Overweight by Morgan Stanley

Posted on: Wednesday,  Sep 9, 2015  12:25 PM ET by Morgan Stanley

Morgan Stanley rated Overweight Akebia Therapeutics Inc. (NASDAQ: AKBA) on 09/09/2015, when the stock price was $11.96. Since
then, Akebia Therapeutics Inc. has lost 45.90% as of 12/15/2015's recent price of $6.47.
If you would have followed this Morgan Stanley's recommendation on AKBA, you would have lost 45.9% of your investment in 97 days.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/9/2015 12:25 PM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy